- Search Results
Search Results For:
Bionano’s annual virtual symposium begins on January 23, 2023.
Event doors will open at 6:30 AM PT/9:30 AM ET/2:30 PM CET
Event begins at 7:00 AM PT/10:00 AM ET/3:00 PM CET
Hear from 25+ global experts sharing how they drive discovery across multiple applications with optical genome mapping (OGM). Learn from presentations, engage in live Q&A, and view posters with the latest scientific research!
Day 1: Hematological Malignancies
Day 2: Solid Tumors
Day 3: Constitutional Genetic Diseases
Day 4: Cell Bioprocessing
Attendance at all sessions of interest is strongly encouraged! Presentations will be available on demand after Symposium 2023 concludes.
Sign up to View On-Demand for this information-packed Bionano-IPM webinar. Dr. Adam Smith describes how his organization, has evaluated optical genome mapping as a first-line test for hematologic malignancies specifically focusing on acute myeloid leukemia and replacing a legacy eosinophilic leukemia FISH panel.
Original Date: Tuesday, August 30, 2022
Adam Smith, Ph.D.
Director, Cancer Cytogenetics Laboratory | University Health Network, Toronto